Clinical Trial Update: Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain

View source ↗

Summary

A Spanish trial by SOLTI examines whether genomic profiling influences treatment decisions for patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: SOLTI Breast Cancer Research Group | Conditions: Metastatic Breast Cancer | Status: RECRUITING